Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver. — Stella

Home/Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)/

View on ClinicalTrials.gov

Recruiting

Back to Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Canada

Centre de recherche du CHUS, Sherbrooke, Quebec

Key details

Sponsor

Université de Sherbrooke

Collaborators

Centre hospitalier universitaire de Québec- Université Laval, Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Enrollment target

~36 participants

Started

April 2026

Primary completion

March 2030

Age range

50 Years – 80 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.